Patent details

EP2471551 Title: Decreasing potential iatrogenic risks associated with influenza vaccines

Basic Information

Publication number:
EP2471551
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP121579452
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Decreasing potential iatrogenic risks associated with influenza vaccines
French Title of Invention:
Diminution des risques iatrogéniques potentiels associés aux vaccins contre la grippe
German Title of Invention:
Verringerung potentieller iatrogener Risiken, die mit Influenza-Impfstoffen zusammenhängen
SPC Number:

Dates

Filing date:
09/09/2005
Grant date:
01/02/2017
EP Publication Date:
01/02/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/07/2012
EP B1 Publication Date:
01/02/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/09/2017
Expiration date:
09/09/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/09/2005
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:
Gregersen Jens Peter
Address:
Germany (DE)

Priority

Priority Number:
04255471
Priority Date:
09/09/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 39/145;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages